Analysed LANTERN PHARMA INC (LTRN:NASDAQ) News Sources
Lantern Pharma Inc (LTRN) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
03-04-2026
yahoo.com
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
02-04-2026
yahoo.com
Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the World's First Multi-Agentic Co-Scientist for Rare Cancers — 8:30 AM Eastern, April 9, 2026
02-04-2026
yahoo.com
Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
30-03-2026
yahoo.com
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
28-03-2026
yahoo.com
Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Report
27-03-2026
yahoo.com
Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001
27-03-2026
yahoo.com
RedChip AI Investor Conference Replays Now Available Highlighting Companies Driving Innovation Across the AI Ecosystem
27-03-2026
yahoo.com
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET
23-03-2026
yahoo.com
What is the current price of LANTERN PHARMA INC (LTRN:NASDAQ)?
The current price of LANTERN PHARMA INC (LTRN:NASDAQ) is $2.22.
LANTERN PHARMA INC (LTRN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LANTERN PHARMA INC (LTRN:NASDAQ) since the previous trading day is $0.25.
LANTERN PHARMA INC (LTRN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LANTERN PHARMA INC (LTRN:NASDAQ) since the previous trading day is 12.6904%.
What is the most recent average sentiment score for LANTERN PHARMA INC (LTRN:NASDAQ)?
The most recent average sentiment score for LANTERN PHARMA INC (LTRN:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for LANTERN PHARMA INC (LTRN:NASDAQ)?
The most recent sentiment for LANTERN PHARMA INC (LTRN:NASDAQ) is .
SEC-8K** Filing Available For LANTERN PHARMA INC (LTRN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.